Commentary · 8 Jun 2026
Conference abstractPublished 13 Jun 2018
Identification of novel ApoE4 inhibitor for alzheimer′s disease therapy
COMSATS Institute of Information Technology, Pakistan
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
ApoE4 is a major genetic risk factor due to its increase incidence of developing alzheimerâÂ?Â?s disease. The study was designed to predict such compounds that may helpful in designing drug to suppress the over activity of apoE4 protein. 22 natural compounds (marine, microorganism and plant derivative) were used as inhibitors and docked with apoE4 (PDB id 1B68). 6 Synthetic compounds (in clinical trials) were docked with target protein to compare and analyze the docking results with natural compounds. Compounds S-allyl-L-cysteine, epicatechin gallate and fulvic acid shows high binding affinity i.e. -7.1, -7 and -7, respectively. Epicatechin gallate shows hydrogen bond with Gln156 and Asp35 and fulvic acid shows hydrogen bonding with Glu27. In case of synthetic compounds tideglusib did not show hydrogen bonding with any amino acid residue of ApoE4 but show high binding affinity of -7.2 same as of natural compound S-allyl-L-cysteine which show high binding affinity of -7.1 but did not show hydrogen bonding with any amino acid residue. Protein-protein interactions of ApoE4 show physical and functional interaction with related proteins. Our study predict a compound epicatechin gallate on the basis of binding affinity and hydrogen bonding with amino acid residue as a potential lead compound which may be used as an inhibitor.
Subjects
Neuroscience & NeurologyAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Journal of Alzheimers Disease & Parkinsonism.
Perspective · 8 Jun 2026
Oxidative Stress and Its Role in Neuronal Degeneration: Mechanisms and Implications
Commentary · 8 Jun 2026
Understanding the Pathophysiology of Prion-Induced Dementia
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Alzheimers Disease & Parkinsonism
- SubjectNeuroscience & Neurology
- BylineArticles whose byline prints “Muhammad Asif Rasheed”